Palantir stock's risen 520% over the past 12 months and 38% over one month. Dr James Fox asks whether he’s missed the boat on ...

Palantir's stock is seeing a boost from reports that the U.S. and Saudi Arabian governments have reached a new deal that ...

Palantir stock has been on a tear in 2025, rising more than 40% even after Tuesday's big drop. Analysts have expressed ...

While Cisco's valuation never fully recovered, the company's current market cap of $236 billion is still far greater than it ...

Software-maker Palantir exceeded high expectations for its first-quarter earnings results but its shares still fell sharply ...

The Wall Street bank reiterated a Buy rating for Palantir and raised its forecast from $125 per share to $150, implying ...

Palantir stock tumbled Tuesday as investors scrutinized the company's high valuation and declining sales to international ...

Palantir shares have advanced 550% since January 2024, which makes it the best performing stock in the S&P 500 and the second ...

Palantir upped full-year guidance and delivered an above-consensus guide for Q2 FY 2025, thereby completing a triple play.

Although Palantir Technologies Inc. (PLTR) stock has a “nosebleed” valuation, it does look attractive, based on the ...

Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Despite elevated volatility for the broader market, Palantir (NASDAQ: PLTR) stock saw explosive gains across April's trading.